Your midterm hold would align with the majority of investors here. If you consider that the China Grand options are linked to the completion of an already advanced license arrangement that is being formalised.
The evidence of CG’s commitment to developing this sector is abundantly clear in their dealings with fellow trial stage radiological Telix, CG have committed to completion within six months of listing so license deal will be completed before then. Investors can view the reaction Tlx’s market cap has experienced since that contract was announced.
IPO - Clarity Pharmaceuticals Ltd - 25 August 2021 #, page-18
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.24 |
Change
0.020(0.38%) |
Mkt cap ! $1.632B | |||
| Open | High | Low | Value | Volume |
| $5.26 | $5.29 | $5.13 | $4.811M | 927.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4354 | $5.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.24 | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |